Symposium: Interpreting patient-reported outcome data – what does it all mean?
Hosted by the Cancer Research Network PRO-SIG
Location:Norman Gregg Lecture Theatre Edward Ford Building (A27) The University of Sydney (Camperdown campus)
The Cancer Research Network Patient-Reported Outcomes Special Interest Group (PRO-SIG) is hosting a symposium on interpreting patient-reported outcome (PRO) data.
Collecting PRO data is easy - turning it into useable information is more challenging. But if PRO results are not interpretable, they are of little value or consequence.
This event will help researchers and clinicians understand how to interpret the clinical relevance of PRO results. It brings together two researchers who have each made significant contributions to solving these challenges over the past 20 years - our international guest, Dr Kathleen Wyrwich, and our own Professor Madeleine King. They have both presented many workshops on this topic, nationally and internationally – this is the first time they have shared a podium.Their perspectives are very complementary – making this a particularly informative symposium:
Dr Kathleen Wyrwich, Eli Lilly and Company, USA
“Methods for interpreting meaningful individual changes over time”
This presentation will include established quantitative methods and emerging methods that lean towards qualitative patient data inputs.
Professor Madeleine King, Chair in Cancer Quality of Life, The University of Sydney
“Methods for interpreting differences in PROs between trial arms: a case study using the EORTC QLQ-C30“
This presentation will provide an example of how to interpret the quality of life endpoints from a randomised clinical trial.
Monday 21 May 2018 at 3-5pm (followed light refreshments)
Please register by Monday 14 May for catering purposes – REGISTER NOW: http://surveys.rws.medfac.usyd.edu.au/index.php/975176?newtest=Y